Large-scale testing (Phase 3)Study completedNCT02289352
What this trial is testing
Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea
Who this might be right for
Rosacea
Actavis Inc. 462